Bauer Jake 4
4 · Immunovant, Inc. · Filed Apr 9, 2026
Research Summary
AI-generated summary of this filing
Immunovant Director Jake Bauer Receives RSUs and Options
What Happened
Jake Bauer, a director of Immunovant, was granted equity awards on April 7, 2026: 13,880 restricted stock units (RSUs) and an award covering 7,061 option-linked shares (both reported as acquired at $0.00). These are compensation grants (not open-market purchases or sales) and carry no immediate cash cost to the reporting person.
Key Details
- Transaction date: 2026-04-07; Form 4 filed 2026-04-09.
- Grants: 13,880 RSUs and 7,061 option-linked shares, acquisition price reported $0.00.
- Vesting: Both the RSUs and the shares underlying the options vest in full on April 1, 2027, subject to Bauer’s continuous service through that date (see footnotes).
- Post-transaction holdings: Not specified in the filing.
- Notable footnotes:
- RSUs represent a contingent right to receive one share per unit on vesting; the reporting person may elect to defer settlement of vested RSUs subject to Rule 409A.
- The option-linked award vests on the same schedule; the filing does not state exercise price or whether any immediate sale/cashless exercise will occur.
Context
These are standard equity compensation awards to a director rather than an open-market purchase or sale. Grants at $0.00 reflect that shares/units were awarded, not bought; they typically vest over time and therefore do not necessarily indicate immediate bullish trading by the insider.
Insider Transaction Report
- Award
Common Stock
[F1]2026-04-07+13,880→ 38,896 total - Award
Stock Option (right to buy)
[F2]2026-04-07+7,061→ 7,061 totalExercise: $24.61Exp: 2036-04-07→ Common Stock (7,061 underlying)
Footnotes (2)
- [F1]These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in full on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.
- [F2]These options were granted pursuant to the Plan. The shares underlying the options will vest on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date.